ATAI
clinical evidence efficacy on cognitive in a phase study | ATAI
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
27 of 34
Similar slides by ATAI
See diffirences between slides (animation)
Investor Presentation
October 2023
clinical evidence efficacy on cognitive in a phase study | ATAI
Related slides by other companies
Adagio Therapeutics
Results
November 2023
the canopy phase clinical trial of is designed to rapidly generate clinical data for a potential | Adagio Therapeutics
Aeglea BioTherapeutics
Investor Presentation
July 2023
is rapidly developing combination products given clinical evidence of substantial efficacy enhancement | Aeglea BioTherapeutics
MindMed
Investor Presentation
December 2024
phase trial schematic schematic week a dose optimization study of | MindMed
Recursion Pharmaceuticals
Investor Day
January 2023
clinical phase studies well tolerated with no dose dependent adverse events in sad and mad mad study placebo further confidence confirming safety | Recursion Pharmaceuticals
Other recent decks by ATAI
See all presentations (13 decks)
Investor Presentation
October 2023
Investor Conference
May 2023
Investor Presentation
April 2023
Investor Presentation
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights